Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Ataxin 10 Antikörper (C-Term)

ATXN10 Reaktivität: Human, Ratte, Maus IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN965623
  • Target Alle Ataxin 10 (ATXN10) Antikörper anzeigen
    Ataxin 10 (ATXN10)
    Bindungsspezifität
    • 16
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reaktivität
    • 32
    • 31
    • 24
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    Human, Ratte, Maus
    Wirt
    • 38
    • 3
    Kaninchen
    Klonalität
    • 41
    • 1
    Polyklonal
    Konjugat
    • 20
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser Ataxin 10 Antikörper ist unkonjugiert
    Applikation
    • 32
    • 14
    • 13
    • 13
    • 9
    • 5
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    Immunohistochemistry (IHC)
    Aufreinigung
    Purified by antigen-specific affinity chromatography.
    Immunogen
    Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to C-terminal residues of human ATXN10(Ataxin-10)
    Top Product
    Discover our top product ATXN10 Primärantikörper
  • Applikationshinweise
    ELISA, Western blotting: 1µg/ml for 2hrs.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    This antibody is stored in PBS, 50% glycerol
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
  • Matsuura, Fang, Pearson, Jayakar, Ashizawa, Roa, Nelson: "Interruptions in the expanded ATTCT repeat of spinocerebellar ataxia type 10: repeat purity as a disease modifier?" in: American journal of human genetics, Vol. 78, Issue 1, pp. 125-9, (2005) (PubMed).

    Wiemann, Weil, Wellenreuther, Gassenhuber, Glassl, Ansorge, Böcher, Blöcker, Bauersachs, Blum, Lauber, Düsterhöft, Beyer, Köhrer, Strack, Mewes, Ottenwälder, Obermaier, Tampe, Heubner, Wambutt, Korn et al.: "Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs. ..." in: Genome research, Vol. 11, Issue 3, pp. 422-35, (2001) (PubMed).

    Matsuura, Yamagata, Burgess, Rasmussen, Grewal, Watase, Khajavi, McCall, Davis, Zu, Achari, Pulst, Alonso, Noebels, Nelson, Zoghbi, Ashizawa: "Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10." in: Nature genetics, Vol. 26, Issue 2, pp. 191-4, (2000) (PubMed).

  • Target
    Ataxin 10 (ATXN10)
    Andere Bezeichnung
    ATXN10 (ATXN10 Produkte)
    Synonyme
    ATXN10 antikoerper, MGC97716 antikoerper, atxn10 antikoerper, Ataxin-10 antikoerper, si:dkeyp-15g12.2 antikoerper, E46L antikoerper, HUMEEP antikoerper, SCA10 antikoerper, Sca10 antikoerper, AI325283 antikoerper, C77170 antikoerper, E46 antikoerper, TEG-169 antikoerper, Tex169 antikoerper, ataxin 10 antikoerper, ATXN10 antikoerper, atxn10 antikoerper, Atxn10 antikoerper
    Hintergrund
    The autosomal dominant cerebellar ataxias (ADCAs) are a clinically and genetically heterogeneous group of disorders characterized by ataxia, dysarthria, dysmetria, and intention tremor. All ADCAs involve some degree of cerebellar dysfunction and a varying degree of signs from other components of the nervous system. Defects in ATXN10 are the cause of spinocerebellar ataxia type 10. SCA10 is an autosomal dominant disorder and is predominantly characterized by cerebellar ataxia seizures. In addition patients often show soft pyramidal signs, ocular dyskinesia, cognitive impairment, and/or behavioral disturbances. SCA10 has been recognized only in families of Mexican origin. The molecular basis of the disease is due to an ATTCT nucleotide repeat expansion in intron 9.
Sie sind hier:
Kundenservice